A Trial of Neoadjuvant Everolimus Plus Letrozole Versus FEC in Women With ER-positive, HER2-negative Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Cyclophosphamide
Related studies linked through entity extraction aliases.
An Investigational Immuno-Therapy Study of Experimental Medication BMS-986178 by Itself or in Combination With Nivolumab and/or Ipilimumab in Participants With Solid Cancers That Are Advanced or Have Spread
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study of Brentuximab Vedotin, Rituximab, and Dose Attenuated CHP in Elderly Patients With Diffuse Large B-Cell Lymphoma (DLBCL)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Personalized NK Cell Therapy in CBT
- Status
- RECRUITING
- Phase
- PHASE2
Reduced Craniospinal Radiation Therapy and Chemotherapy in Treating Younger Patients With Newly Diagnosed WNT-Driven Medulloblastoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
International Randomised Phase III Clinical Trial in Children With Acute Myeloid Leukaemia
- Status
- RECRUITING
- Phase
- PHASE3
A Phase 2 Study of Ruxolitinib With Chemotherapy in Children With Acute Lymphoblastic Leukemia
- Status
- COMPLETED
- Phase
- PHASE2
UCB Transplant for Hematological Diseases Using a Non Myeloablative Prep
- Status
- COMPLETED
- Phase
- PHASE2
JCAR014 and Durvalumab in Treating Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma
- Status
- TERMINATED
- Phase
- PHASE1
Sequential, Related Donor Partial Liver Transplantation Followed by Bone Marrow Transplantation for Hepatocellular Carcinoma (HCC)
- Status
- WITHDRAWN
- Phase
- PHASE2
Addition of Vismodegib to Neoadjuvant Chemotherapy in Triple Negative Breast Cancer Patients
- Status
- UNKNOWN
- Phase
- PHASE2
A Study to Evaluate the Efficacy and Safety of Mabthera Alone and in Combination With Either Cyclophosphamide or Methotrexate in Patients With Rheumatoid Arthritis
- Status
- COMPLETED
- Phase
- PHASE2
Competitive Transfer of αCD19-TCRz-CD28 and αCD19-TCRz-CD137 CAR-T Cells for B-cell Leukemia/Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Neoadjuvant Chemotherapy Docetaxel With or Without SELUMETINIB in Patients With Triple Negative Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Addition of PD-L1 Antibody MEDI4736 to a Taxane-anthracycline Chemotherapy in Triple Negative Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Phase II Study of Intraventricular Methotrexate in Children With Recurrent or Progressive Malignant Brain Tumors
- Status
- TERMINATED
- Phase
- PHASE2
Denosumab as an add-on Neoadjuvant Treatment (GeparX)
- Status
- COMPLETED
- Phase
- PHASE2
Nonmyeloablative Conditioning for Mismatched Hematopoietic Stem Cell Transplantation for Severe Sickle Cell Disease
- Status
- TERMINATED
- Phase
- PHASE1
Study of Ibrutinib in Combination With Rituximab-CHOP in Epstein-Barr Virus-positive Diffuse Large B-cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Autologous Hematopoietic Stem Cell Transplantation as Adjuvant Treatment for Triple Negative Breast Cancer Patients
- Status
- UNKNOWN
- Phase
- PHASE2